Skip to main content

Advertisement

SpringerLink
Log in

Cholesterol levels in patients with multiple myeloma

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Hypocholesterolemia is seen in solid tumors and some hematological malignancies. We assessed cholesterol levels and the relationship between these levels and types and stages of multiple myeloma (MM) in the patients with MM. One-hundred two patients (60 male and 42 female) of mean age 59 ± 11 years with MM were enrolled to this study. While 71.6% of the patients were Ig G type, 80.4% of the patients were at stage III. In the control group, there were 71 healthy persons (42 male and 29 female) of mean age 58 ± 8 years. The levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) in the patients with MM were significantly lower than the controls (p < 0.001). There was no difference for the levels of very-low-density lipoprotein cholesterol and triglyceride between the two groups (p > 0.05). Lipid parameters were not different between Ig types (p > 0.05). The levels of TC and LDL-C in the patients with stage I were higher than those of stages II and III (p < 0.001 and p < 0.005, respectively). The levels of TC and LDL-C in the controls were not higher than the patients with stage I (p > 0.05). HDL-C levels in the patients with stage III were lower than controls (p < 0.001). Hypocholesterolemia are seen in the patients with MM. Hypocholesterolemia may be due to increased LDL clearance and utilization of cholesterol by myeloma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Castelli WP (1984) Epidemiology of coronary heart disease. The Framingham study. Am J Med 76:4–12

    Article  PubMed  CAS  Google Scholar 

  2. Ginsberg HN, Goldberg IJ (1998) Disorders of lipoprotein metabolism. In: Fauci SA, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper LD, Hauser LS, Longo LD (eds) Harrison’s principles internal medicine, 14st edn. Mcgraw-Hill, New York, pp 2138–2149

    Google Scholar 

  3. Muller G, Schilf K (1987) Hypocholestreolemia. Z Gesamte Inn Med 42:310–313 (Abstract)

    PubMed  CAS  Google Scholar 

  4. Tomiki Y, Suda S, Tanaka M, Okuzawa A, Matsuda M, Ishibiki Y, Sakamato K, Kamano T, Tsurumaru M, Watanabe Y (2004) Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study. J Exp Clin Cancer Res 23:233–240

    PubMed  CAS  Google Scholar 

  5. Siemianowicz K, Gminski J, Stajszczyk M, Wojakowski W, Goss M, Machalski M, Telega A, Brulinski K, Magiera-Molendowska H (2000) Serum total cholesterol and triglycerides levels in patients with lung cancer. Int J Mol Med 5:201–205

    PubMed  CAS  Google Scholar 

  6. Gadomska H, Janecki J, Marianowski L, Nowicka G (1997) Lipids in serum of patients with malignant ovarian neoplasms. Int J Gynaecol Obstet 57:287–293

    Article  PubMed  CAS  Google Scholar 

  7. Quesney-Huneeus V, Galick HA, Siperstein MD, Erickson SK, Spencer TA, Nelson JA (1983) The dual role of mevalonate in cell cycle. J Biol Chem 258:378–385

    PubMed  CAS  Google Scholar 

  8. Gal D, Ottashi M, Macdonald PC, Buschbaum HJ, Simpson ER (1981) Low density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. Am J Obstet Gynecol 139:877–885

    PubMed  CAS  Google Scholar 

  9. Niendorf A, Nagele H, Gerding D, Meyer-Pannwitt U, Gebhardt A (1995) Increased LDL receptor mRNA expression in colon cancer is correlated with rise in plasma cholesterol levels after curative surgery. Int J Cancer 6:461–464

    Article  Google Scholar 

  10. Vassiliou G, Benoist F, Lau P, Kavaslar GN, Mcpherson P (2001) The low density lipoprotein receptor-related protein contributes to selective uptake of HDL-cholesteryl esters by Sw872 liposarcoma cells and primary human adipocytes. J Biol Chem 276:48823–48830

    Article  PubMed  CAS  Google Scholar 

  11. Peterson C, Vitols S, Rudling M, Blomgren H, Edsmyr F, Skoog L (1985) Hypocholesterolemia in cancer patients may be caused by elevated LDL receptor activities in malignant cells. Med Oncol Tumor Pharmacother 2:143–147

    PubMed  CAS  Google Scholar 

  12. Allampallam K, Dutt D, Nair C, Shetty V, Mundle S, Lisak L, Andrews C, Ahmed B, Mazzone L, Zorat F, Borok R, Muzammil M, Gundroo A, Ansaarie I, Raza A (2000) The clinical and biological significance of abnormal lipid profiles in patients with myelodysplastic syndromes. J Hematother Stem Cells 9:247–255

    Article  CAS  Google Scholar 

  13. Goncalves RP, Rodrigues DG, Maranhao RC (2005) Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells. Leuk Res 29:955–959

    Article  PubMed  CAS  Google Scholar 

  14. Pandolfino J, Hakimian D, Rademaker AW, Tallman MS (1997) Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activity. Am J Hematol 55:129–133

    Article  PubMed  CAS  Google Scholar 

  15. Musolino C, Calabro L, Bellomo G, Cincotta M, Di Giacomo V, Pezzano C, Loteta B, Rizzo B, Guglielmo S, Alonci A (2002) Lipid profile in hematologic neoplasms. Recenti Prog Med 93:298–301 (Abstract)

    PubMed  Google Scholar 

  16. Rudling M, Gafvels M, Parini P, Gahrton G, Angelin B (1998) Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation. Am J Pathol 153:1923–1935

    PubMed  CAS  Google Scholar 

  17. Tatidis L, Vitols S, Bruber A, Paul C, Axelson M (2001) Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of circulating marker for bile acid synthesis. Cancer Letters 170:169–175

    Article  PubMed  CAS  Google Scholar 

  18. Aviram M, Brook JG, Tatarsky I, Levy Y, Carter A (1986) Increased low density lipoprotein levels after splenectomy: a role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am J Med Sci 29:25–28

    Article  Google Scholar 

  19. Dispenzeri A, Lacy MQ, Greipp PR (2004) Multiple myeloma. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B (eds) Wintrobe’s clinical hematology, 11st edn. Lippincott Williams–Wilkins, Philadelphia, pp 2583–2636

    Google Scholar 

  20. Bruno B, Rotta M, Giaccone L, Massaia M, Bertola A, Palumbo A, Baccadora M (2004) New drugs for treatment of multiple myeloma. Lancet Oncol 5:430–442

    Article  PubMed  CAS  Google Scholar 

  21. Li JL, Li YJ, Chao YJ, Lin LX, Ouyang MH, Peng YB, Chang WS (1991) Cholesterol requirement for growth of Ir983f and P3x63-Ag8-U1 myeloma cells in serum-free medium. Cytobios 68:15–22

    PubMed  CAS  Google Scholar 

  22. Sato JD, Kawamoto T, Okamoto T (1987) Cholesterol requirement of P3-X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro. J Exp Med 165:1761–1766

    Article  PubMed  CAS  Google Scholar 

  23. Aixala M, Sarandria CN, Speroni JG (1997) Hypocholesterolemia in hematologic neoplasms. Sangre 42:7–10 (Abstract)

    PubMed  CAS  Google Scholar 

  24. Scolozzi R, Boccafogli A, Salmi R, Furlani MR, Guidoboni CA, Vicentini L, Coletti M, Tocchetto M (1983) Hypocholesterolemia in multiple myeloma. Inverse relation to the component M and the clinical stage. Minerva Med 74:2359–2364 (Abstract)

    PubMed  CAS  Google Scholar 

  25. Hachem H, Favre G, Ghalim N, Puchois P, Fruchart JC, Soula G (1987) Quantitative abnormalities of lipoprotein particles in multiple myeloma. J Clin Chem Clin Biochem 25:675–679

    PubMed  CAS  Google Scholar 

  26. Levy Y, Aviram M, Spira G, Tatarsky I, Brook GJ, Carter A (1984) Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies. Postgraduate Med J 60:449–453

    Article  CAS  Google Scholar 

  27. Van De Donk NW, Kamphuis MM, Lokhorst HM, Bloem AC (2002) The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells. Leukemia 16:1362–1371

    Article  PubMed  CAS  Google Scholar 

  28. Gronich N, Drucker L, Shapiro H, Radnay J, Yarkoni S, Lishner M (2004) Simvastatin induces death of multiple myeloma cell lines. J Investig Med 52:335–344

    Article  PubMed  CAS  Google Scholar 

  29. Van Der Spek E, Bloem AC, Van De Donk NW, Rogers LH, Van Der Griend R, Kramer MH, De Weerdt O, Wittebol S, Lokhorst HM (2006) Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma. Haematologica 91:542–545

    PubMed  Google Scholar 

  30. International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the international myeloma working group. Br J Haematol 121:749–757

    Article  Google Scholar 

  31. Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 36:842–854

    Article  PubMed  CAS  Google Scholar 

  32. Friedewald WT, Levy RI, Fredrikson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:449–502

    Google Scholar 

  33. Mahley RW, Weisgraber KH, Farese RV (1998) Disorders of lipid metabolism. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds) Williams textbook of endocrinology, 9th edn. Saunders, Philadelphia, pp 1099–1153

    Google Scholar 

  34. Hungria VT, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhao RC (2004) Metabolism of a cholesterol-rich microemulsion (Lde) in patients with multiple myeloma and a preliminary clinical study of Lde as a drug vehicle for the treatment of the disease. Cancer Chemother Pharmacol 53:51–60

    PubMed  CAS  Google Scholar 

  35. Tsuchiya J (1989) Some problems in the laboratory findings in multiple myeloma. Nippon Ketsueki Gakkai Zasshi 52:1273–1278 (Abstract)

    PubMed  CAS  Google Scholar 

  36. Osadchy A, Drucker L, Radnay J, Shapira H, Lishner M (2004) Microenvironment factors do not afford myeloma cell lines protection from simvastatin. Eur J Haematol 73:183–190

    Article  PubMed  CAS  Google Scholar 

  37. Van De Donk NW, Lokhorst HM, Nijhuis EH, Kamphuis MM, Bloem EC (2005) Geranylgeranylated proteins are involvedin the regulation of myeloma cell growth. Clin Cancer Res 11:429–439

    PubMed  Google Scholar 

  38. Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini E (2000) Non-lipid related effects of statins. Ann Med 32:164–176

    PubMed  CAS  Google Scholar 

  39. Thibault A, Samid D, Tompkins AC, Wigg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE (1996) Phase I study of lovastatin, an inhibitor of the mevalonate pathway in patients with cancer. Clin Cancer Res 2:483–491

    PubMed  CAS  Google Scholar 

  40. Kim WS, Kim MM, Choi HJ, Yoon SS, Lee MH, Park K, Park CH, Kang WK (2001) Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma. Invest New Drugs 19:81–83

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Adnan Menderes University Faculty of Medicine, 09100, Aydin, Turkey

    Irfan Yavasoglu, Gurhan Kadikoylu & Zahit Bolaman

  2. Division of Hematology, Ege University Medical Faculty, Izmir, Turkey

    Murat Tombuloglu, Ayhan Donmez & Seckin Cagırgan

Authors
  1. Irfan Yavasoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Murat Tombuloglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gurhan Kadikoylu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ayhan Donmez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seckin Cagırgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zahit Bolaman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irfan Yavasoglu.

Additional information

We did not receive any financial support, and this study has not been published in any journal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yavasoglu, I., Tombuloglu, M., Kadikoylu, G. et al. Cholesterol levels in patients with multiple myeloma. Ann Hematol 87, 223–228 (2008). https://doi.org/10.1007/s00277-007-0375-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-007-0375-6

Keywords

Search

Navigation